Delayed Antibiotic Prescription by General Practitioners in the UK: A Stated-Choice Study
- PMID: 32947965
- PMCID: PMC7558347
- DOI: 10.3390/antibiotics9090608
Delayed Antibiotic Prescription by General Practitioners in the UK: A Stated-Choice Study
Abstract
Delayed antibiotic prescription in primary care has been shown to reduce antibiotic consumption, without increasing risk of complications, yet is not widely used in the UK. We sought to quantify the relative importance of factors affecting the decision to give a delayed prescription, using a stated-choice survey among UK general practitioners. Respondents were asked whether they would provide a delayed or immediate prescription in fifteen hypothetical consultations, described by eight attributes. They were also asked if they would prefer not to prescribe antibiotics. The most important determinants of choice between immediate and delayed prescription were symptoms, duration of illness, and the presence of multiple comorbidities. Respondents were more likely to choose a delayed prescription if the patient preferred not to have antibiotics, but consultation length had little effect. When given the option, respondents chose not to prescribe antibiotics in 51% of cases, with delayed prescription chosen in 21%. Clinical features remained important. Patient preference did not affect the decision to give no antibiotics. We suggest that broader dissemination of the clinical evidence supporting use of delayed prescription for specific presentations may help increase appropriate use. Establishing patient preferences regarding antibiotics may help to overcome concerns about patient acceptance. Increasing consultation length appears unlikely to affect the use of delayed prescription.
Keywords: UK; antibiotic resistance; choice experiment; delayed prescription; general practice; primary care; respiratory tract infection; stewardship.
Conflict of interest statement
The authors declare no conflict of interest. The funders played no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or PHE.
Figures




References
-
- O’Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. [(accessed on 1 May 2019)]; Available online: https://wellcomecollection.org/works/thvwsuba.
-
- Davies S. Annual Report of the Chief Medical Officer 2011: Volume 2. Department of Health and Social Care; London, UK: 2013.
-
- Public Health England English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR): Report 2018–2019. [(accessed on 20 February 2020)]; Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploa....
-
- OpenPrescribing.net, EBM DataLab, University of Oxford, Oxford. [(accessed on 1 July 2020)]; Available online: https://openprescribing.net/bnf/0501/
Grants and funding
LinkOut - more resources
Full Text Sources